Sign in Request access
Sign inRequest access
OpenTender 5 Oct 2028, 23:59 (UTC+02:00)

Open-House-Verträge 2026 - Aflibercept (Kopie)

At a glance

AOK Bremen/Bremerhaven is procuring Pharmaceutical products (CPV 33600000). The notice gives 5 October 2028, 23:59 (UTC+02:00) as the deadline. Procedure type: Open.

From the notice

Open-House-Verträge für Wirkstoff bis 30.11.2028

Key facts

Each fact is from the official notice, last checked 7 November 2026, 04:30 (UTC+01:00).

Status
OpenOfficial notice · checked 7 Nov 2026, 04:30 (UTC+01:00)
Deadline
(in 698 days)Official notice · checked 7 Nov 2026, 04:30 (UTC+01:00)
Buyer
AOK Bremen/Bremerhaven, Bremen, DEOfficial notice · checked 7 Nov 2026, 04:30 (UTC+01:00)
Main CPV
Pharmaceutical products (CPV 33600000)Official notice · checked 7 Nov 2026, 04:30 (UTC+01:00)
Procedure
OpenOfficial notice · checked 7 Nov 2026, 04:30 (UTC+01:00)
Lots
1Official notice · checked 7 Nov 2026, 04:30 (UTC+01:00)
First published
23 September 2026, 17:48 (UTC+02:00)Official notice · checked 7 Nov 2026, 04:30 (UTC+01:00)

Fact sheet

Inteliwert fact sheet: Open-House-Verträge 2026 - Aflibercept (Kopie) — AOK Bremen/Bremerhaven, deadline 5 October 2028, 23:59 (UTC+02:00). A product of Bandpey GmbH.
The key facts of this page as an image (PNG, 1600 × 900), made from the official notice. © Bandpey GmbH; terms of use. Download the fact sheet

Lots (1)

  1. Lot LOT-0001: Aflibercept ATC Code S01LA05

    Im Open House Verfahren sind Arzneimittel entsprechend der BfArM-Liste nach § 35 Abs. 5a SGB V (Kinderarzneimittel) ausgeschlossen. Gegenstand dieser Veröffentlichung ist der Abschluss von Verträgen nach § 130a Abs. 8 SGB V über verschiedene Wirkstoffe im Rahmen eines sogenannten Open-House-Verfahrens. Unter Vorgabe einheitlicher Vertragskonditionen sowie eines einheitlichen Zugangsverfahrens wird allen geeigneten und interessierten pharmazeutischen Unternehmen oder Gemeinschaften pharmazeutischer Unternehmen der Abschluss bzw. Beitritt zu einem Rabattvertrag nach § 130a Abs. 8 SGB V über den genannten Wirkstoff angeboten. Der früheste Vertragsbeginn ist der 01.11.2026, Vertragsende ist der 30.11.2028. Ein Beitritt zu diesem Open-House-Verfahren ist innerhalb der Vertragslaufzeit jederzeit möglich. Bitte seien Sie so nett und übersenden uns bei Interesse, gerne vorab per E-Mail, den in 2-facher Ausfertigung unterschriebenen Rabattvertrag unter Berücksichtigung der Kinderarzneimittel-Liste des BfArM.

    CPV
    Pharmaceutical products (CPV 33600000)
    Deadline

Timeline

  1. 23 September 2026, 17:48 (UTC+02:00): Original notice Notice, version 01 (Contract or concession notice – standard regime). Official notice

Buyer and place

Buyer

AOK Bremen/Bremerhaven
Bremen, DE

Classification

CPV codes

  • 33600000: Pharmaceutical products

Official documents

Links go to the publisher. Inteliwert does not copy the documents.

Questions and answers

When is the deadline?

The official notice gives 5 October 2028, 23:59 (UTC+02:00) as the deadline.

Who is the buyer?

AOK Bremen/Bremerhaven, Bremen, DE.

What is being procured (CPV)?

Pharmaceutical products (CPV 33600000).

Is it divided into lots?

No, the notice names a single lot.

Which procedure is used?

Open.

How do I submit a bid?

On the official notice or the portal it names. Inteliwert does not submit bids. Official notice

Am I eligible?

Inteliwert does not judge eligibility. The selection criteria are in the official notice. Official notice

Companies that might fit

Possible match based on public information

Companies Inteliwert knows from its sources, not the whole market. Inteliwert does not judge eligibility, fit or chances.

  • Bluefish Pharma GmbH

    Griesheim
    SME (from the award notice)
    • Won a contract in CPV group 336 (2026-10-05) Evidence · checked 7 Nov 2026
    • 4 awards in this field in 36 months, from 1 buyer Evidence · checked 7 Nov 2026

  • Gedeon Richter GmbH

    Eschborn
    SME (from the award notice)
    • Won a contract in CPV group 336 (2026-10-05) Evidence · checked 7 Nov 2026
    • 3 awards in this field in 36 months, from 1 buyer Evidence · checked 7 Nov 2026

  • Amarox Pharma GmbH

    Haar
    SME (from the award notice)
    • Won a contract in CPV group 336 (2026-10-05) Evidence · checked 7 Nov 2026
    • 4 awards in this field in 36 months, from 1 buyer Evidence · checked 7 Nov 2026

  • HEC Pharm GmbH

    Berlin
    SME (from the award notice)
    • Won a contract in CPV group 336 (2026-10-05) Evidence · checked 7 Nov 2026
    • 3 awards in this field in 36 months, from 1 buyer Evidence · checked 7 Nov 2026

  • APONTIS PHARMA Deutschland GmbH & Co. KG

    Monheim am Rhein
    SME (from the award notice)New to public tenders
    • Won a contract in CPV group 336 (2026-09-29) Evidence · checked 7 Nov 2026
    • 1 award in this field in 36 months, from 1 buyer Evidence · checked 7 Nov 2026

More from this buyer

Other published opportunities of this buyer in the indexed notices, open ones first.

Source

Publisher
Bekanntmachungsservice
Licence
CC0 1.0
Last checked
7 November 2026, 04:30 (UTC+01:00)

The official notice is authoritative. Inteliwert shows what the notice states and links to it.

Markdown version